Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Non-cash Items (2016 - 2017)

Historic Non-cash Items for Corcept Therapeutics (CORT) over the last 3 years, with Q4 2017 value amounting to $263.1 million.

  • Corcept Therapeutics' Non-cash Items rose 241293.1% to $263.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $263.1 million, marking a year-over-year increase of 241293.1%. This contributed to the annual value of $263.1 million for FY2017, which is 241293.1% up from last year.
  • As of Q4 2017, Corcept Therapeutics' Non-cash Items stood at $263.1 million, which was up 241293.1% from $10.5 million recorded in Q4 2016.
  • In the past 5 years, Corcept Therapeutics' Non-cash Items ranged from a high of $263.1 million in Q4 2017 and a low of $10.5 million during Q4 2016